In oncology, a hazard ratio (HR) is commonly used to estimate the treatment effect for survival endp...
Read moreThe QALY Shortfall aims to capture and recognise disease severity by assessing the degree of quality...
Read moreAn overview of the product life cycle. The product life cycle must be managed efficiently to generat...
Read moreInsights from pharmaceuticals, market access and Team Remap Q3 2021.
Read moreWe outline the 3 key components of a good value proposition, designed to demonstrate the value of ne...
Read moreInnovative therapies for rare diseases may only be available in a select number of countries in Euro...
Read moreThe introduction of new medicines in England requires the cooperation of industry and the NHS.
Read moreNICE is increasing opportunities for patient engagement by simplifying the process and increasing pa...
Read morePatents are usually only valid for around 20 years however, as patenting occurs early in the R&D pro...
Read moreReal-world evidence (RWE) refers to clinical and economic evidence which has been derived from the a...
Read more